Glypican-3 reexpression regulates apoptosis in murine adenocarcinoma mammary cells modulating PI3K/Akt and p38MAPK signaling pathways

作者：Buchanan C; Stigliano I; Garay Malpartida H M; Gomes L Rodrigues; Puricelli L; Sogayar M C; de Kier Joffe E Bal; Peters M G^*

来源：Breast Cancer Research and Treatment, 2010, 119(3): 559-574.

DOI：10.1007/s10549-009-0362-9

• Glypican-3
• Apoptosis
• PI3K/Akt pathway
• p38MAPK pathway
• Breast cancer

Glypican-3 (GPC3) is a proteoglycan involved in proliferation and cell survival. Several reports demonstrated that GPC3 is downregulated in some tumors, such as breast cancer. Previously, we determined that GPC3 reexpression in the murine mammary adenocarcinoma LM3 cells induced an impairment of their invasive and metastatic capacities, associated with a decrease of their motility and an increase of their cell death. We demonstrated that GPC3 inhibits canonical Wnt signaling, as well as it activates non canonical pathway. Now, we identified signaling pathways responsible for the pro-apoptotic role of GPC3 in LM3 cells. We found for the first time that GPC3 inhibits the PI3K/Akt anti-apoptotic pathway while it stimulates the p38MAPK stress-activated one. We report a concomitant modulation of CDK inhibitors as well as of pro- and anti-apoptotic molecules. Our results provide new clues regarding the mechanism involved in the modulation induced by GPC3 of mammary tumor cell growth and survival.

• 出版日期2010-2